Le Lézard
Classified in: Science and technology
Subject: PDT

PlayTesting.gg Launches Real-Time, Streamlined Game Testing Platform


New Easy-to-Use Service Offers Quick, Cost Effective, and Comprehensive Testing For Developers Across Various Platforms.

CUPERTINO, Calif., May 23, 2024 /PRNewswire/ -- PlayTesting.gg today announced the availability of its game testing platform, designed to radically streamline the quality assurance (QA) process for individual developers and major game studios to deliver better games faster.

The platform simplifies and expedites game testing with a real-time insights dashboard and a pay-as-you-go pricing model that sets a new industry standard. Game developers can now submit games, receive immediate insights on gameplay issues, and easily implement resolutions, with a platform that is up to 4x more cost effective than existing solutions. 

"PlayTesting.gg bridges the gap between quality and cost in game testing," said Idan Beck, Founder and CEO of PlayTesting.gg. "Our real-time dashboard and pay-as-you-go pricing model is designed specifically to address the need for quick and effective game testing for developers, regardless of their size. Our mission is to transform the gaming industry's traditional QA processes, and we believe PlayTesting.gg is a major leap toward this goal."

Key Benefits

Streamlined, Real-Time Feedback: Developers receive immediate insights into bugs and gameplay issues via a live dashboard, enabling faster resolutions compared to traditional testing methods.

Cost Effective Testing Services: The pay-as-you-go pricing model offers up to 4x the cost-efficiency of standard industry rates, providing a viable solution for both independent developers and large studios.

User-Friendly Platform: An intuitive dashboard allows developers to effortlessly submit games, track identified issues, and implement immediate resolutions, simplifying the QA process.

Game Variety: PlayTesting.gg supports PC, Android, iOS, and consoles, addressing the needs of a wide array of game developers and studios.

Pricing and Availability
PlayTesting.gg is available today on the web with a pay-as-you-go pricing model.

About PlayTesting.gg
PlayTesting.gg is an innovative game testing platform giving developers immediate insights on bugs and gameplay issues via a real-time dashboard, while offering a cost-effective, easy-to-use solution for both indie developers and major studios across various platforms. Backed by leading investors, PlayTesting.gg aims to become the go-to platform for game testing. To learn more about PlayTesting.gg visit the Web, X, Discord, and LinkedIn.

All registered trademarks and product identifiers belong to their respective corporate entities. Any other trademarks or product names referenced here are also owned exclusively by their relevant companies.

Media Contact:
Gary Bird
FortyThree, Inc.
831.888.9011
[email protected]

SOURCE PlayTesting.gg


These press releases may also interest you

at 08:05
BreachBits Announces Agreement Between SentryMark and Nippon Telematique for Distribution of BreachRisktm Solutions in Japan
BreachBits, Inc. announced a reseller partnership between SentryMark, Inc. and Nippon Telematique, Inc. (NTI) to distribute BreachRisktm solutions in Japan. BreachBits delivers attack surface monitoring (ASM) and automated penetration testing...

at 07:07
CCTV+: Father's Influence on Xi to Be Public Servant of People
For Chinese President Xi Jinping, words and deeds of his father Xi Zhongxun (1913-2002) embodying the principle of "being a public servant of the people" are a great family heirloom that runs deep in his outlook on life, work, and philosophy....

at 07:05
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial
Positive results from the ECHO Phase III trial showed AstraZeneca's CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab demonstrated a statistically significant and clinically meaningful improvement in progression-free survival...

at 03:50
Electra Therapeutics Presents Late-Breaking Clinical Data at EHA2024 from Ongoing Phase 1b Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Electra Therapeutics, Inc., a clinical stage biotechnology company developing antibody therapies against novel targets for immunological diseases and cancer, announced the presentation of clinical data for ELA026 in secondary hemophagocytic...

at 02:21
Procolored Celebrates 6th Anniversary with 1st Global Brand Seminar in Long Beach, California
Procolored, a global leader in the production of lightweight inkjet printers, celebrated its sixth...

at 02:16
Print-on-demand Solution Provider Procolored Showcases Latest Innovations at Graphics Pro Expo 2024
The Graphics Pro Expo (GPX) is a major event for the digital graphics market and printing industry, where participants can access the latest products, learn new technologies and techniques in digital printing. This exhibition gathers professionals...

More news about Science and technology...


News published on and distributed by: